F, Y., CW, L., D, Z., HL, W., X, W., & M, Y. (2025). Oral contrast-enhanced ultrasonographic features and radiomics analysis to predict NIH risk stratification for gastrointestinal stromal tumors. Frontiers in oncology, 15, 1590432. https://doi.org/10.3389/fonc.2025.1590432
Chicago Style (17th ed.) CitationF, Yang, Liu CW, Zhang D, Wang HL, Wei X, and Yang M. "Oral Contrast-enhanced Ultrasonographic Features and Radiomics Analysis to Predict NIH Risk Stratification for Gastrointestinal Stromal Tumors." Frontiers in Oncology 15 (2025): 1590432. https://doi.org/10.3389/fonc.2025.1590432.
MLA (9th ed.) CitationF, Yang, et al. "Oral Contrast-enhanced Ultrasonographic Features and Radiomics Analysis to Predict NIH Risk Stratification for Gastrointestinal Stromal Tumors." Frontiers in Oncology, vol. 15, 2025, p. 1590432, https://doi.org/10.3389/fonc.2025.1590432.